• Peptide Therapy Innovations for Triple Negative Breast Cancer

  • May 30 2024
  • Duración: 20 m
  • Podcast

Peptide Therapy Innovations for Triple Negative Breast Cancer

  • Resumen

  • The Cancer Advances podcast is joined by Ofer Reizes, PhD, the Laura J. Fogarty Endowed Chair for Uterine Cancer Research, and Justin Lathia, PhD, Melvin H. Burkhardt Endowed Chair for Neuro-Oncology Research, Scientific Director of the Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, and the Vice Chair of the Department of Cardiovascular and Metabolic Sciences at Cleveland Clinic's Lerner Research Institute to discuss their research on peptide therapy as a targeted treatment for triple negative breast cancer. Listen as they explain their collaborative efforts to develop therapeutic peptides that disrupt cancer stem cell programs, the process of their work, and the potential for expanding peptide therapy to other cancer types.

    Más Menos
activate_WEBCRO358_DT_T2

Lo que los oyentes dicen sobre Peptide Therapy Innovations for Triple Negative Breast Cancer

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.